Tonix Pharmaceuticals Holding Corp. (TNXP)
13.16
-0.20
(-1.53%)
USD |
NASDAQ |
Sep 04, 14:45
Tonix Pharmaceuticals Cash from Investing (Quarterly) : -0.5769M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5769M |
| March 31, 2026 | -1.692M |
| December 31, 2025 | -1.019M |
| September 30, 2025 | -1.032M |
| June 30, 2025 | -2.648M |
| March 31, 2025 | -0.006M |
| December 31, 2024 | -0.0014M |
| September 30, 2024 | -0.0126M |
| June 30, 2024 | 0.0018M |
| March 31, 2024 | -0.108M |
| December 31, 2023 | -0.0986M |
| September 30, 2023 | -1.120M |
| June 30, 2023 | -24.43M |
| March 31, 2023 | -3.799M |
| December 31, 2022 | -5.031M |
| September 30, 2022 | -8.754M |
| June 30, 2022 | -13.70M |
| March 31, 2022 | -20.22M |
| December 31, 2021 | -25.42M |
| September 30, 2021 | -7.662M |
| June 30, 2021 | -1.424M |
| March 31, 2021 | -0.505M |
| December 31, 2020 | -4.716M |
| September 30, 2020 | -4.163M |
| June 30, 2020 | -0.014M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.005M |
| September 30, 2019 | -0.0021M |
| June 30, 2019 | -0.003M |
| March 31, 2019 | -0.007M |
| December 31, 2018 | 0.001M |
| September 30, 2018 | -0.003M |
| June 30, 2018 | -0.0019M |
| March 31, 2018 | -0.002M |
| December 31, 2017 | -0.0233M |
| September 30, 2017 | -0.0706M |
| June 30, 2017 | 2.549M |
| March 31, 2017 | 4.694M |
| December 31, 2016 | 3.901M |
| September 30, 2016 | 5.241M |
| June 30, 2016 | 2.734M |
| March 31, 2016 | 4.718M |
| December 31, 2015 | -1.925M |
| September 30, 2015 | -22.09M |
| June 30, 2015 | -0.153M |
| March 31, 2015 | 0.00 |
| December 31, 2014 | -0.125M |
| September 30, 2014 | -0.16M |
| June 30, 2014 | -0.105M |
| March 31, 2014 | -0.002M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Exelixis, Inc. | 91.43M |
| Inovio Pharmaceuticals, Inc. | 6.147M |
| Heron Therapeutics, Inc. | -3.265M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -41.87M |
| Cash from Financing (Quarterly) | 33.27M |
| Free Cash Flow | -160.40M |
| Free Cash Flow Per Share (Quarterly) | -2.552 |
| Free Cash Flow to Equity (Quarterly) | -42.43M |
| Free Cash Flow to Firm (Quarterly) | -42.44M |
| Free Cash Flow Yield | -95.44% |